Rare diseases
Investigational molecules
Locations
Praxis Ebertplatz Ebertplatz 1 50668 Köln, 50668 Cologne, Germany
Praxis Ebertplatz in Cologne, Germany specialises in clinical trials of conditions such as HIV infection, COVID-19, Chronic hepatitis B, Hepatitis B, and other specialisations. This site conducts important research.
The medical center is at the forefront of HIV-1 treatment research, focusing on innovative therapeutic strategies to enhance patient outcomes. The center's research is dedicated to evaluating the efficacy of novel treatment regimens, such as the combination of bictegravir and lenacapavir, in maintaining viral suppression in individuals who are already successfully treated.
Through its pioneering research, the center contributes significantly to the development of more effective and patient-friendly treatment options, aiming to improve the quality of life for those living with HIV-1.
Clinical trials currently enrolling participants at this site.
Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness
GermanyStudy on the Effectiveness of Cabotegravir and Rilpivirine for People with HIV-1 Who Have Not Responded Well to Oral Treatment
GermanyStudy Comparing Bictegravir/Lenacapavir to Current Therapy in People with HIV-1 Who Are Successfully Treated
GermanyStudy of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment
GermanyStudy Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy
GermanyStudy on Pamapimod and Pioglitazone for COVID-19 Recovery in Non-Hospitalized Patients
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
